Home/Filings/4/0001104659-22-011491
4//SEC Filing

Strem Brian M. 4

Accession 0001104659-22-011491

CIK 0001372514other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:01 PM ET

Size

5.7 KB

Accession

0001104659-22-011491

Insider Transaction Report

Form 4
Period: 2022-02-01
Strem Brian M.
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-01+75,00075,000 total
    Exercise: $0.77Exp: 2032-02-01Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.

Issuer

KIORA PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1
  • filerCIK 0001876429

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:01 PM ET
Size
5.7 KB